Cheshire, CT, United States of America

Timothy S McConnell


Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Timothy S. McConnell: Pioneering Bifunctional Heterocyclic Compounds

Introduction: Timothy S. McConnell is a prominent inventor based in Cheshire, Connecticut, known for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, McConnell is dedicated to developing innovative compounds that serve various therapeutic purposes. His work primarily focuses on bifunctional heterocyclic compounds, which demonstrate promising applications in treating various medical conditions.

Latest Patents: McConnell's latest inventions include groundbreaking patents for bifunctional heterocyclic compounds. The first patent describes a family of these compounds that are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The invention provides methods for both making and utilizing these compounds effectively. The second patent similarly covers a family of compounds that are aimed at combating infections and proliferative conditions like cancer. These compounds are designed to function as chemotherapeutic, anti-fungal, anti-bacterial, anti-parasitic, and anti-viral agents, as well as anti-inflammatory and prokinetic agents, enhancing the potential therapeutic options available in modern medicine.

Career Highlights: McConnell is currently employed at Rib-X Pharmaceuticals, Inc., a company recognized for its innovative approaches in drug development. His contributions to the pharmaceutical industry are characterized by a commitment to advancing medical treatments through innovative chemical solutions. McConnell's research addresses critical health challenges, leading to potential breakthroughs in therapeutic applications.

Collaborations: Throughout his career, McConnell has had the opportunity to collaborate with distinguished colleagues such as Deping Wang and Joyce A. Sutcliffe. These collaborations highlight a synergistic approach to research and development, fostering an environment of innovation and discovery.

Conclusion: Timothy S. McConnell stands as a notable figure in the realm of drug development, with his patents paving the way for new therapeutic options. His work in designing bifunctional heterocyclic compounds showcases the potential for innovation in combating various health issues. As he continues to collaborate with fellow researchers, the future looks promising for McConnell and his contributions to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…